目的研究血管生成抑制剂SU6668对胃癌生长和转移的抑制作用。
Objective to study the effect of angiogenesis inhibitor SU6668 on the growth and metastasis of gastric cancer in SCID mice.
在这两种模型中通过基因消融血管内皮生长因子- A也发现侵袭性增加，证实药理抑制剂的结果。
Increased invasiveness is also seen by genetic ablation of the Vegf-A gene in both models, substantiating the results of the pharmacological inhibitors.
肿瘤血管生成抑制剂是一类能破坏或抑制血管生成，有效地阻止肿瘤生长和转移的药物。
Tumor angiogenesis inhibitor is a class of new drugs that can destroy or inhibit tumor neovascularization, and can effectively block the growth and metastasis of cancer.
随着分子生物学研究的进展，表皮生长因子受体抑制剂、血管内皮生长因子抑制剂等分子靶向药物的研究成为热点之一。
With the advancement of the study of molecular biology, the research of the molecular targeted drugs such as EGFR inhibitor and VEGF inhibitor, become one of the hot spots.
使用特定药理学制剂如抗氧化剂和PKC抑制剂，靶向血管内皮生长因子表达可能证明对治疗糖尿病性视网膜病变是有效的。
Targeting VEGF expression with specific pharmacological agents, such as antioxidants and PKC inhibitors, may prove efficacious for the treatment of diabetic retinopathy.
使用特定药理学制剂如抗氧化剂和PKC抑制剂，靶向血管内皮生长因子表达可能证明对治疗糖尿病性视网膜病变是有效的。
Targeting VEGF expression with specific pharmacological agents, such as antioxidants and PKC inhibitors, may prove efficacious for the treatment of diabetic retinopathy.
应用推荐